Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech North Carolina.
Press releases published on August 25, 2025
Houzeo Launches ‘Collections’ — A Smarter Way for North Carolina Buyers to Organize Their Home Searches
Houzeo’s newest upgrade in the Favorites feature lets buyers sort their favorite homes into personalized wishlists. CHARLOTTE, NC, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- Houzeo, America's best home buying app, has introduced Collections—an …
BuilderComs Prepares to Launch Messaging First Project Management Platform Built by Real User Demand
After years as a messaging platform, BuilderComs evolves into full project management, built directly from user demand. EMERALD ISLE, NC, UNITED STATES, August 25, 2025 /EINPresswire.com/ -- BuilderComs announced today that it is preparing to roll out a …
Geotab and Healthy Heads in Trucks & Sheds Forge Premier Partnership to Champion Mental Health and Safety in Australia's Logistics Sector
SYDNEY, Aug. 26, 2025 (GLOBE NEWSWIRE) -- In a move to support the conversation around mental health in Australia's supply chain, Geotab Inc. (“Geotab”), a global leader in connected vehicle and asset solutions, has joined forces with Healthy Heads in …
BlackRock® Canada Announces Final August Cash Distributions for the iShares® Premium Money Market ETF
TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (NYSE: BLK), today announced the final August 2025 cash distributions for iShares Premium …
Correction: Diginex Announces 8 to 1 Stock-split paid as Bonus Shares
Diginex Limited (Nasdaq: DGNX) (the “Company”), announced today corrections to the headline and first paragraph of its press release sent out on August 18, 2025. The corrected release follows: Diginex Announces 8 to 1 Stock-split paid as Bonus Shares …
ANI Pharmaceuticals to Present at Upcoming Investor Conferences
PRINCETON, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership team …
A New Class by Conscious Web Presence That Makes Website Building Less Scary October 6 2025
Philadelphia, PA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- For many entrepreneurs, artists, and healers, the hardest part of launching a business isn’t the work itself—it’s getting online. A new evening class in the Philadelphia suburbs aims to change that. …
XRP News: Sparkvia AI Debuts the First AI-Powered Writing Platform on XRP Ledger—Igniting Creativity On-Chain
VALLETTA, Malta, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Sparkvia AI, an innovator at the intersection of artificial intelligence and blockchain, today announced the official debut of its flagship writing platform, the first fully AI-powered content creation …
Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson’s Disease under 505(b)(2) NDA Pathway
- U.S. IND filing planned for Q4 2025 with U.S. enrollment expected to start in Q1 2026 - Patient dosing expected to begin in Australia in Q4 2025 HUNTSVILLE, AL, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), …
Memgen Announces First Patient Dosed in Phase 1 Combination Cohort of MEM-288 Plus Docetaxel in Advanced Non–Small Cell Lung Cancer
TAMPA, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Memgen, Inc., a clinical-stage biotechnology company developing oncolytic immunotherapy for solid tumors, today announced the dosing of the first patient in its Phase 1 combination cohort evaluating …
Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025
SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases …
zSpace to Present at the 2025 Gateway Conference on September 4th
SAN JOSE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- zSpace, Inc. (NASDAQ: ZSPC) (“zSpace” or the “Company”), a leader in immersive augmented reality (AR) solutions for education, is confirmed to present at the 2025 Annual Gateway Conference, which is being …
Kyverna Therapeutics to Present at Upcoming Investor Conferences in September
EMERYVILLE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that Warner Biddle, …
Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline
BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system (CNS) disorders, today announced its participation in the …
EWC 2025 Concludes in Riyadh: OBSBOT Elevates Esports Viewing Experience with AI-Powered Videography
Riyadh, Saudi Arabia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- After seven weeks of electrifying competition, the Esports World Cup 2025 (EWC 2025), the world’s largest esports and gaming event, concluded in Riyadh, marking another milestone in the history of …
With GWM Brazil Plant Opening, Global Standards Meet Local Manufacturing
São Paulo, Brazil, Aug. 25, 2025 (GLOBE NEWSWIRE) -- GWM officially inaugurated its Brazil Plant in Iracemápolis, São Paulo, marking its first full-process manufacturing hub in South America. With annual production capacity set to grow from 20,000 to 50, …
Tevogen Sees Continued Growth in Institutional Ownership in Q2 2025; 72% of Holders Increased or Maintained Positions
WARREN, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced an update on institutional ownership of the Company’s outstanding common stock, as reported by institutional investment …
Practice AI™ Expands AI Demands with Powerful New Case Valuation and Verdict Analysis Capabilities
WOODLAND HILLS, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Practice AI™ is proud to announce the latest expansion of its flagship AI Demands product. The platform now includes built-in case valuation intelligence and verdict analysis tools embedded in the …
UPDATE – Climb Bio to Present at Upcoming September 2025 Investor Conferences
WELLESLEY HILLS, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that members of its executive team will participate in …